Search

Delia M. Ramirez

Examiner (ID: 4462)

Most Active Art Unit
1652
Art Unit(s)
1652
Total Applications
1518
Issued Applications
818
Pending Applications
200
Abandoned Applications
534

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18808986 [patent_doc_number] => 20230383321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => IMPROVED METHOD FOR THE PRODUCTION OF ISOPRENOIDS [patent_app_type] => utility [patent_app_number] => 17/998703 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29959 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998703 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998703
IMPROVED METHOD FOR THE PRODUCTION OF ISOPRENOIDS May 16, 2021 Pending
Array ( [id] => 19418460 [patent_doc_number] => 20240294583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => GENETICALLY MODIFIED MICROORGANISM AND METHOD FOR PRODUCING ORGANIC ACID [patent_app_type] => utility [patent_app_number] => 17/924145 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11509 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924145 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/924145
GENETICALLY MODIFIED MICROORGANISM AND METHOD FOR PRODUCING ORGANIC ACID May 10, 2021 Pending
Array ( [id] => 19474083 [patent_doc_number] => 12104160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Production of 4,6-dihydroxy-2-oxo-hexanoic acid [patent_app_type] => utility [patent_app_number] => 17/307850 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 57627 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307850 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/307850
Production of 4,6-dihydroxy-2-oxo-hexanoic acid May 3, 2021 Issued
Array ( [id] => 18376260 [patent_doc_number] => 20230151343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => GENOME EDITING USING CAS9 OR CAS9 VARIANT [patent_app_type] => utility [patent_app_number] => 17/919588 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919588 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/919588
GENOME EDITING USING CAS9 OR CAS9 VARIANT Apr 25, 2021 Pending
Array ( [id] => 18376260 [patent_doc_number] => 20230151343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => GENOME EDITING USING CAS9 OR CAS9 VARIANT [patent_app_type] => utility [patent_app_number] => 17/919588 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919588 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/919588
GENOME EDITING USING CAS9 OR CAS9 VARIANT Apr 25, 2021 Pending
Array ( [id] => 18739898 [patent_doc_number] => 20230348865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => ENGINEERED ENZYMES AND METHODS OF MAKING AND USING [patent_app_type] => utility [patent_app_number] => 17/996921 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33436 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -63 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996921 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996921
ENGINEERED ENZYMES AND METHODS OF MAKING AND USING Apr 22, 2021 Pending
Array ( [id] => 19594428 [patent_doc_number] => 12152258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-26 [patent_title] => Optimized protein fusions and linkers [patent_app_type] => utility [patent_app_number] => 17/235921 [patent_app_country] => US [patent_app_date] => 2021-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19785 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235921 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/235921
Optimized protein fusions and linkers Apr 19, 2021 Issued
Array ( [id] => 19847081 [patent_doc_number] => 20250092432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => NITRILASE MUTANT AND USE THEREOF IN CATALYTIC SYNTHESIS OF 2-CHLORONICOTINIC ACID [patent_app_type] => utility [patent_app_number] => 18/018561 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2641 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018561 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/018561
NITRILASE MUTANT AND USE THEREOF IN CATALYTIC SYNTHESIS OF 2-CHLORONICOTINIC ACID Apr 18, 2021 Pending
Array ( [id] => 17156377 [patent_doc_number] => 20210317428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/225878 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225878 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/225878
Modified cells comprising CRISPR systems Apr 7, 2021 Issued
Array ( [id] => 17185453 [patent_doc_number] => 20210332338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS [patent_app_type] => utility [patent_app_number] => 17/224054 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224054 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/224054
FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS Apr 5, 2021 Abandoned
Array ( [id] => 18658066 [patent_doc_number] => 20230304048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => RECOMBINANT MICROORGANISMS AND PROCESS [patent_app_type] => utility [patent_app_number] => 17/916137 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916137 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916137
RECOMBINANT MICROORGANISMS AND PROCESS Mar 30, 2021 Pending
Array ( [id] => 18658066 [patent_doc_number] => 20230304048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => RECOMBINANT MICROORGANISMS AND PROCESS [patent_app_type] => utility [patent_app_number] => 17/916137 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916137 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916137
RECOMBINANT MICROORGANISMS AND PROCESS Mar 30, 2021 Pending
Array ( [id] => 18349028 [patent_doc_number] => 20230137139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS [patent_app_type] => utility [patent_app_number] => 17/914060 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68317 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -60 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914060 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/914060
BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS Mar 25, 2021 Pending
Array ( [id] => 16948491 [patent_doc_number] => 20210207182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => METHOD FOR PRODUCING L-METHIONINE USING A BACTERIUM [patent_app_type] => utility [patent_app_number] => 17/211479 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 727 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17211479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/211479
METHOD FOR PRODUCING L-METHIONINE USING A BACTERIUM Mar 23, 2021 Abandoned
Array ( [id] => 16948423 [patent_doc_number] => 20210207114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY [patent_app_type] => utility [patent_app_number] => 17/210129 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16327 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -93 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210129 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/210129
Engineering of DNASE enzymes for manufacturing and therapy Mar 22, 2021 Issued
Array ( [id] => 17097189 [patent_doc_number] => 20210284980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY [patent_app_type] => utility [patent_app_number] => 17/210219 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24737 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210219 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/210219
RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY Mar 22, 2021 Abandoned
Array ( [id] => 17905742 [patent_doc_number] => 11459588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides [patent_app_type] => utility [patent_app_number] => 17/208146 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 24919 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208146 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/208146
Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides Mar 21, 2021 Issued
Array ( [id] => 18306919 [patent_doc_number] => 20230110819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => BIO-BASED NYLON PRECURSORS HAVING REDUCED ORGANIC AND INORGANIC IMPURITIES [patent_app_type] => utility [patent_app_number] => 17/911409 [patent_app_country] => US [patent_app_date] => 2021-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/911409
BIO-BASED NYLON PRECURSORS HAVING REDUCED ORGANIC AND INORGANIC IMPURITIES Mar 13, 2021 Pending
Array ( [id] => 17830438 [patent_doc_number] => 20220267742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => NADPH-REGENERATION SYSTEM BASED ON MONOMERIC ISOCITRATE DEHYDROGENASE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/189143 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8496 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189143 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/189143
NADPH-REGENERATION SYSTEM BASED ON MONOMERIC ISOCITRATE DEHYDROGENASE AND USE THEREOF Feb 28, 2021 Abandoned
Array ( [id] => 16932749 [patent_doc_number] => 20210198638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF ARMODAFINIL [patent_app_type] => utility [patent_app_number] => 17/184427 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31786 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184427 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/184427
Biocatalysts and methods for the synthesis of armodafinil Feb 23, 2021 Issued
Menu